Acceptance-Based Treatment for Prostate Cancer Distress
- Conditions
- Early Stage Prostate Cancer
- Interventions
- Behavioral: Acceptance and Commitment Therapy
- Registration Number
- NCT01594593
- Lead Sponsor
- Veterans Medical Research Foundation
- Brief Summary
Prostate cancer (PCa) is the most common type of cancer in men and the second leading cause of death in American men. Those diagnosed with localized prostate cancer encounter three sources of psychological distress: 1) diagnosis itself, 2) treatment decision making, and 3) the often life-altering side effects of treatment. In addition, patients who choose to undergo active surveillance which focuses on monitoring cancer in lieu of treatment, experience distress related to living with cancer. Acceptance and Commitment Therapy (ACT) is an established psychosocial intervention that has been used extensively for mental health treatment and has shown benefits for various chronic conditions. ACT is a behavioral intervention that focuses on tolerating distress and improving function. This pilot study is designed to test the feasibility of ACT for distress reduction and improved quality of life in patients recently diagnosed with early-stage, localized PCa.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 24
- Localized prostate cancer in Stages I or II
- Ability to give informed consent
- Age 18 to 80 years old
- Willingness to come in for a day long intervention
- Acute psychosis
- Suicidal ideation
- Homicidal ideation
- Active substance abuse
- Dementia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Acceptance and Commitment Therapy Acceptance and Commitment Therapy Group-based behavioral workshop to address cancer-related distress
- Primary Outcome Measures
Name Time Method Number of dropouts 6 months Because this is a pilot study to determine feasibility, one of the primary outcomes is the number of participants who drop out of the active treatment arm.
Number of refusals 6 months Because this is a pilot study to determine feasibility, one of the primary outcomes is the number of participants who refuse the active treatment arm.
- Secondary Outcome Measures
Name Time Method Hospital Anxiety and Depression Scale baseline, post intervention, 2 weeks post intervention, 3 months post intervention Memorial Anxiety Scale for Prostate Cancer baseline, post intervention, 2 weeks post intervention, 3 months post intervention
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
VA San Diego Healthcare System
🇺🇸San Diego, California, United States